Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kaye

Showing results (291-300 of 411) with videos related to

Pageof 42
Sort By:
British Journal of Cancer|February 5, 2004
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumoursD A Anthoney, M J McKean, J T Roberts, et al.
Gynecologic Oncology|October 1, 1983
Cervical carcinoma: a drug-responsive tumor--experience with combined cisplatin, vinblastine, and bleomycin therapyM Friedlander, S B Kaye, A Sullivan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcomaR C Stuart-Harris, P G Harper, C A Parsons, et al.
Journal of Oral Pathology|August 1, 1984
The oral carriage of yeasts and coliforms in patients on cytotoxic therapyL P Samaranayake, K C Calman, M M Ferguson, et al.
The British Journal of Ophthalmology|November 15, 2015
The impact of donor age and endothelial cell density on graft survival following penetrating keratoplastyM J Wakefield, W J Armitage, M N A Jones, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
British Journal of Cancer|November 1, 1988
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonistJ Cassidy, V Raina, C Lewis, et al.
The Australian and New Zealand Journal of Surgery|June 1, 1985
EORTC Genito-Urinary Group studies in advanced testicular cancer--past and futureS B Kaye, W W Bokkel-Huinink, A T van Oosterom, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTGJ Cassidy, M A Graham, W Ten Bokkel Huinink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacologyS G Allan, J Cummings, S Evans, et al.
Pageof 42

Showing results (291-300 of 411) with videos related to

Sort By:
Pageof 42
British Journal of Cancer|February 5, 2004
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumoursD A Anthoney, M J McKean, J T Roberts, et al.
Gynecologic Oncology|October 1, 1983
Cervical carcinoma: a drug-responsive tumor--experience with combined cisplatin, vinblastine, and bleomycin therapyM Friedlander, S B Kaye, A Sullivan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcomaR C Stuart-Harris, P G Harper, C A Parsons, et al.
Journal of Oral Pathology|August 1, 1984
The oral carriage of yeasts and coliforms in patients on cytotoxic therapyL P Samaranayake, K C Calman, M M Ferguson, et al.
The British Journal of Ophthalmology|November 15, 2015
The impact of donor age and endothelial cell density on graft survival following penetrating keratoplastyM J Wakefield, W J Armitage, M N A Jones, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
British Journal of Cancer|November 1, 1988
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonistJ Cassidy, V Raina, C Lewis, et al.
The Australian and New Zealand Journal of Surgery|June 1, 1985
EORTC Genito-Urinary Group studies in advanced testicular cancer--past and futureS B Kaye, W W Bokkel-Huinink, A T van Oosterom, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTGJ Cassidy, M A Graham, W Ten Bokkel Huinink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacologyS G Allan, J Cummings, S Evans, et al.
Pageof 42